diff --git a/pages/STOP2030___Web___Posts.md b/pages/STOP2030___Web___Posts.md
index 85d498e5..bc6c6363 100644
--- a/pages/STOP2030___Web___Posts.md
+++ b/pages/STOP2030___Web___Posts.md
@@ -5,6 +5,6 @@
 	- #+BEGIN_VERSE
 	  At STOP2030 we want to provide a pharmacological tool that helps at delivering WHO's goals for soil-transmitted helminthiasis (STH). That is why we're happy to announce that the REALISE study (Real world Evaluation of an ALbendazol-Ivermectin coformulation Safety and Effectiveness), our most ambitious clinical trial, has been approved for publication in clinicaltrials.gov and the Pan African Clinical Trial Registry.
 	  
-	  This clinical trial is a Cohort Event Study aimed at evaluating both the safety and effectiveness of our fixed-dose coformulation of albendazol and ivermectin within  large populations, matched against the standard dose albendazole currently in use against STH. We expect to recruit around 20 thousand people.
+	  This clinical trial is a Cohort Event Study aimed at evaluating the safety and effectiveness of our fixed-dose coformulation of albendazol and ivermectin within  large populations, matched against the standard dose albendazole currently in use against STH. We expect to recruit around 20 thousand people.
 	  
 	  #+END_VERSE
\ No newline at end of file